中药治疗对HIV/AIDS神经系统疾病患者死亡风险的影响
本研究基于2010-2017年1209例HIV/AIDS合并神经系统疾病患者,比较308例中药使用者和901例非使用者,发现中药使用者全因死亡风险降低70%(aHR=0.30,95%CI:0.16-0.58,p<0.001),感染、寄生虫和循环相关死亡风险降低86%(aHR=0.14,95%CI:0.04-0.46,p=0.001),并识别出两个重要中药组合。
要点
- 中药使用与全因死亡风险降低70%相关(aHR=0.30)。
- 中药使用与感染、寄生虫和循环相关死亡风险降低86%相关(aHR=0.14)。
- 重要中药组合包括黄芩、甘草、黄连、桔梗、黄柏及酸枣仁汤、夜交藤。
核心结论
- 中药可能对HIV/AIDS合并神经系统疾病患者有效,但需未来临床试验验证。
研究设计与样本
- 研究识别2010-2017年1209例HIV/AIDS合并神经系统疾病患者,其中308例中药使用者,901例非使用者。
- 采用Kaplan-Meier法、log-rank检验和Cox比例风险模型分析,并用关联规则挖掘和网络分析确定中药组合。
主要发现
- 中药使用者全因死亡风险降低70%(aHR=0.30,95%CI:0.16-0.58,p<0.001),log-rank检验p=0.0007。
- 中药使用者感染、寄生虫和循环相关死亡风险降低86%(aHR=0.14,95%CI:0.04-0.46,p=0.001),log-rank检验p=0.0010。
- 关联规则挖掘和网络分析显示两个中药组合对神经系统疾病患者重要。
关键数值与推荐
- 第一个中药组合中,黄芩、甘草、黄连、桔梗、黄柏为重要中药,黄连与黄芩连接强度最强。
- 第二个中药组合中,酸枣仁汤和夜交藤为重要中药,连接强度最强。
临床怎么用
- 对于HIV/AIDS合并神经系统疾病患者,可考虑在专业指导下使用中药,尤其是包含黄芩、黄连等或酸枣仁汤、夜交藤的组合。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction: Long-term living with human immunodeficiency virus (HIV) and/or antiretroviral therapy (ART) is associated with various adverse effects, including neurocognitive impairment. Heterogeneous neurocognitive impairment remains an important issue, affecting between 15-65% of human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS) patients and resulting in work performance, safety, and health-related outcomes that have a heavy economic burden. Methods: We identified 1,209 HIV/AIDS patients with neurological diseases during 2010-2017. The Kaplan-Meier method, log-rank test, and Cox proportional hazards model were used to analyze 308 CHM users and 901 non-CHM users within this population. Major CHM clusters were determined using association rule mining and network analysis. Results and Discussion: Results showed that CHM users had a 70% lower risk of all-cause mortality (adjusted hazard ratio (aHR) = 0.30, 95% confidence interval (CI):0.16-0.58, p < 0.001) (p = 0.0007, log-rank test). Furthermore, CHM users had an 86% lower risk of infections, parasites, and circulatory-related mortality (aHR = 0.14, 95% confidence interval (CI):0.04-0.46, p = 0.001) (p = 0.0010, log-rank test). Association rule mining and network analysis showed that two CHM clusters were important for patients with neurological diseases. In the first CHM cluster, Huang Qin (HQ; root of Scutellaria baicalensis Georgi), Gan Cao (GC; root of Glycyrrhiza uralensis Fisch.), Huang Lian (HL; root of Coptis chinensis Franch.), Jie Geng (JG; root of Platycodon grandiflorus (Jacq.) A.DC.), and Huang Bai (HB; bark of Phellodendron amurense Rupr.) were identified as important CHMs. Among them, the strongest connection strength was identified between the HL and HQ. In the second CHM cluster, Suan-Zao-Ren-Tang (SZRT) and Ye Jiao Teng (YJT; stem of Polygonum multiflorum Thunb.) were identified as important CHMs with the strongest connection strength. CHMs may thus be effective in treating HIV/AIDS patients with neurological diseases, and future clinical trials are essential for the prevention of neurological dysfunction in the population.
引用
- Chiou JS, Chou CH, Ho MW, et al. Effect of Chinese herbal medicine therapy on risks of all-cause mortality, infections, parasites, and circulatory-related mortality in HIV/AIDS patients with neurological diseases. Front Pharmacol. 2023. PMID: 36937878. doi:10.3389/fphar.2023.1097862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。